The efficacy of immunoglobulin replacement therapy in the longterm follow-up of the B-cell deficiencies (XLA, HIM, CVID)

Bayrakci, BENAN; Ersoy, F; Sanal, O; Kilic, S; Metin, A; Tezcan, I

The efficacy of immunoglobulin replacement therapy in the longterm follow-up of the B-cell deficiencies (XLA, HIM, CVID)

Bayrakci B., Ersoy F., Sanal O., Kilic S., Metin A., Tezcan I.

TURKISH JOURNAL OF PEDIATRICS, cilt.47, sa.3, ss.239-246, 2005 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 47 Sayı: 3
Basım Tarihi: 2005
Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.239-246
Anahtar Kelimeler: immunoglobulin, infection, hospitalization, complication, adverse reaction, COMMON VARIABLE IMMUNODEFICIENCY, DOSE INTRAVENOUS IMMUNOGLOBULIN, X-LINKED AGAMMAGLOBULINEMIA, PRIMARY HYPOGAMMAGLOBULINEMIA, IGM
Hacettepe Üniversitesi Adresli: Evet

Özet

Immunoglobulin replacement therapy is the essential treatment of B-cell deficiencies. Because of the high expense of therapy, optimal dose, infusion intervals and serum IgG levels should be well defined. Data of 19 X-linked agammaglobulinemia (XLA), 7 hyper-IgM syndrome (HIM) and 20 common variable immunodeficiency (CVID) patients were analyzed.